Top Tweets for #SPESOLIMAB
#ClinicalPearls
#Rx of #PsO
#psoriasis
NEw topicals
ORal - #خان_کی_مزاحمت_کے_1ہزار_دن Icotrokinra , #Deucravacotinib
Bad skin, no joints - #IL23i
bad skin and #PsA #Il17i
#pustular PsO #spesolimab
#CCREast Dr Avery LaChance
⛰️ CONFERENCE HIGHLIGHTS: Long-term extension data from the #EFFISAYIL clinical program, presented at #AAD2026, provide new insights into the sustained efficacy and safety of #spesolimab in generalized pustular psoriasis.
Read more: https://t.co/EYApz8lfte
❗LEO Pharma has completed its acquisition of #spesolimab (#Spevigo), the first FDA-approved treatment for #GPP flares.
https://t.co/sn9Cdzb7Il #DermTwitter
New data from the EFFISAYIL®2 trial show most patients with generalized pustular psoriasis (#GPP) didn’t achieve clear skin with small-molecule drugs. Targeted therapies like #spesolimab may offer better relief. #dermatology #SDPA2025 https://t.co/YH6tkb2mPS
👥 CONFERENCE HIGHLIGHTS: A poster presented at #dermpasummer found #spesolimab improved quality of life in patients with generalized pustular psoriasis.
Read more about the further analysis of the Effisayil 2 trial here: https://t.co/gXBbU1UgBZ
Jason Hawkes, MD, MS, emphasized the importance of early diagnosis and treatment, highlighting the recent approval of #spesolimab for GPP and the need for better biomarkers to differentiate GPP. Learn more and watch his #FCPANP24 interview: https://t.co/AUjXW4p8jv
“While tuberculosis (TB) screening is recommended for #spesolimab use, we believe that initiation of spesolimab may not need to be delayed for patients lacking risk factors for latent TB and symptoms suggestive of active TB.” ➡️ https://t.co/EfMPQ896lj
@JAADjournals @NPF
❤️ Loving it as #SharonChen @LPCH_IDProgram walks us through -nibs &mab mechanisms & how to think thru the link 🔗 between #Mabs & specific pathway infections!! #Adalimumab #Ustekinumab #Spesolimab #Ozanimod #PedsTID #PiTCHID #IDWeek2023
#Spesolimab reduced generalized pustular #psoriasis. In the Effisayil 2 trial of 123 patients, over the 48-week trial, spesolimab significantly decreased the number of GPP flares compared to placebo.
https://t.co/sP2ezwTn9v
Very exciting results on subcutaneous #spesolimab for prevention of flares of generalised pustular #psoriasis #GPP from Effisayil 2 - clear benefit for highest dose for reduction in risk of flares
#WCD2023 #WCD2023Singapore
🔎Explorando nuevos tratamientos para la #HidradenitisSuppurativa
El hospital 12 de Octubre de Madrid es uno de los 11 centros españoles que participa en el estudio con #spesolimab
@dermah12o
It was a pleasure being part of this great Plenary Focus Session on #psoriasis #pustularpsoriasis on the #EADVSymposium with wonderful colleagues Proff. Diamant Thaçi, Tiago Torres @TDermatologia and Bertrand Richert. #spesolimab
JUST IN: @Boehringer Ingelheim's #spesolimab has been approved by regulatory authorities in almost 40 countries to treat GPP flares in adults. #pustularpsoriasis https://t.co/37Jfi7HQTM
#PsoriasisNews: The @EU_Commission approves SPEVIGO (#spesolimab) for Generalized Pustular Psoriasis (#GPP) flares in adults.
For more information, visit: https://t.co/0H6NLsv8Z3
#GPP #PsoriasisRelief #Dermatology
Design of Effisayil™ 2: A Randomized, Double-Blind, Placebo-Controlled Study of #Spesolimab in Preventing Flares in Patients with #GeneralizedPustularPsoriasis: https://t.co/yT36syxhoD #StudyProtocol #PustularPsoriasis #Dermatology
Generalized #pustularpsoriasis, a rare and potentially life-threatening skin disease, now has its 1st FDA-approved therapy: @Boehringer antibody #spesolimab. The IV-infused drug will be marketed as #Spevigo. Boehringer PR:
https://t.co/Mv5R0Dl7gi
#raredisease #biotech #pharma
New Spesolimab Data Show Clinically Significant Improvement In Patients With Generalized Pustular Psoriasis (GPP) Flares
#Spesolimab #Data #Research #Medico #pharma
https://t.co/WxbjjQmufe
Boehringer Ingelheim has reported that its experimental therapy, #spesolimab, substantially improved signs and symptoms of flare in individuals with generalised pustular psoriasis (GPP) in Phase II Effisayil 1 clinical trial.
#jcrb
Quick Take: Spesolimab for Generalized Pustular Psoriasis https://t.co/ca3hhwTpA4
A new @NEJM study evaluating #spesolimab for generalized pustular psoriasis. Speso is an IL36R inhibitor- what did the study find? a brief thread: https://t.co/Fqrq8n6WHJ
Last Seen Hashtags on Sotwe
omegle()*+*+* filter:native_video since:2026-05-11
คนจร
Seen from Thailand
Magrelinha
Seen from United States
وكالة_واس
Seen from United States
omegle
Seen from Thailand
teenageer
Seen from United States
รับงานรามคำแหง
Seen from Thailand
文字コラ ママ
Seen from Japan
kiranrathod leaked
Seen from India
MomentSlimmer
Seen from United States
Most Popular Users
Elon Musk 
@elonmusk
241.5M followers
Barack Obama
@barackobama
119.1M followers
Cristiano Ronaldo
@cristiano
113.6M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.2M followers
Rihanna
@rihanna
98.5M followers
NASA
@nasa
92.4M followers
Justin Bieber
@justinbieber
91.7M followers
KATY PERRY
@katyperry
89.5M followers
Taylor Swift
@taylorswift13
83.5M followers
Lady Gaga
@ladygaga
74.9M followers
Virat Kohli
@imvkohli
72.6M followers
Kim Kardashian
@kimkardashian
70.7M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
65.6M followers
Bill Gates
@billgates
64.9M followers
Selena Gomez
@selenagomez
62.6M followers
The Ellen Show
@theellenshow
62.3M followers
CNN
@cnn
61.8M followers
X
@x
60.8M followers